Бізнес · 11.03.19941 хв читання
Lilly Research Laboratories, et al.; Withdrawal of Approval of 57 Abbreviated Antibiotic Drug Applications
Локальний автоматичний переклад · Оригінальна мова джерела
Короткий зміст
The Food and Drug Administration (FDA) is withdrawing approval of 57 abbreviated antibiotic drug applications (AADA's). The holders of the AADA's notified the agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.